Loading clinical trials...
Loading clinical trials...
The main purpose of the study is to determine the correct dose of empasiprubart in adolescent participants. It also aims to evaluate if empasiprubart may work and how safe it is for the use in childre...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
argenx
NCT07264426 · Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP, and more
NCT06920004 · Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, and more
NCT06747351 · Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
NCT05584631 · CIDP, Immunoglobulin Deficiency, and more
NCT06538064 · Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions